Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 105151-105200 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT03966716
Hips Screws or (Total) Hip Replacement for Undisplaced Femoral Neck Fractures in Elderly Patients (HipSTHeR)
NARecruiting
1,440 participants
Started: Sep 16, 2019 · Completed: Sep 1, 2026
2 conditions2 sponsors25 locations
NCT04094038
The Effect of Intradialytic Parenteral Nutrition on Nutritional Status and Quality of Life in Hemodialysis Patients
PHASE4Active, not recruiting
166 participants
Started: Sep 16, 2019 · Completed: Sep 30, 2025
4 conditions2 sponsors2 locations
NCT04096014
Late Evening and Early Morning Protein Supplement to Reduce Readmissions for Hepatic Encephalopathy
NARecruiting
40 participants
Started: Sep 16, 2019 · Completed: Oct 30, 2026
1 condition1 sponsor1 location
NCT03877939
Detection of Kisspeptins and miRNAs in Patients With Non-viable Pregnancy
N/AEnrolling by invitation
433 participants
Started: Sep 15, 2019 · Completed: Feb 25, 2025
1 condition4 sponsors2 locations
NCT04109586
Diet and Fat Mass After Traumatic Spinal Cord Injury
NAActive, not recruiting
56 participants
Started: Sep 15, 2019 · Completed: Sep 30, 2025
3 conditions3 sponsors1 location
NCT04089943
The Role of microRNA-210 in Regulating Oxidative Stress in Patients With PAD
NAActive, not recruiting
230 participants
Started: Sep 15, 2019 · Completed: Aug 25, 2025
4 conditions2 sponsors2 locations
NCT03972202
The Role of Cerebellum in Speech
NAActive, not recruiting
660 participants
Started: Sep 15, 2019 · Completed: May 31, 2025
3 conditions4 sponsors3 locations
NCT04110821
Quality of Life After Conservative and Surgical Treatment of Pelvic Organ Prolapse
N/ARecruiting
134 participants
Started: Sep 15, 2019 · Completed: Dec 31, 2028
3 conditions1 sponsor1 location
NCT04310644
Autonomic Small Fiber Neuropathy and Ehlers Danlos Syndromes - Prospective Study and Registry
N/ARecruiting
200 participants
Started: Sep 15, 2019 · Completed: Sep 15, 2029
4 conditions2 sponsors1 location
NCT04559048
Investigation of Pain Incidence After FK506 Immunosuppressive Therapy in Liver Transplantation Patients
N/ARecruiting
300 participants
Started: Sep 15, 2019 · Completed: Jun 30, 2024
2 conditions2 sponsors1 location
NCT04290130
Dynamic Neural Mechanisms of Audiovisual Speech Perception
NAEnrolling by invitation
100 participants
Started: Sep 15, 2019 · Completed: May 31, 2026
1 condition3 sponsors1 location
NCT04100395
Global Hemostasis Monitoring by Using Sonoclot Signature in Traumatic Patients
N/ANot yet recruiting
40 participants
Started: Sep 15, 2019 · Completed: Oct 15, 2032
1 condition1 sponsor0 locations
NCT04087772
Enhancing School-Based Violence Prevention
NAActive, not recruiting
4,840 participants
Started: Sep 13, 2019 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04068610
COLUMBIA-1: Novel Oncology Therapies in Combination With Chemotherapy and Bevacizumab as First- Line Therapy in MSS-CRC
PHASE1/PHASE2Active, not recruiting
61 participants
Started: Sep 13, 2019 · Completed: Nov 24, 2025
1 condition1 sponsor21 locations
NCT03952624
Patient-Centered Assessment of Symptoms and Outcomes
N/ARecruiting
692 participants
Started: Sep 13, 2019 · Completed: Jul 1, 2026
8 conditions1 sponsor1 location
NCT03259503
Olaparib and High-Dose Chemotherapy in Treating Patients With Relapsed or Refractory Lymphomas Undergoing Stem Cell Transplant
PHASE1Active, not recruiting
50 participants
Started: Sep 13, 2019 · Completed: Jun 30, 2028
5 conditions2 sponsors1 location
NCT04013542
Ipilimumab and Nivolumab in Combination With Radiation Therapy in Treating Patients With Stage 2-3 Non-small Lung Cancer
PHASE1Active, not recruiting
21 participants
Started: Sep 13, 2019 · Completed: Dec 31, 2027
12 conditions2 sponsors1 location
NCT04115267
Attribution of Toxicities Due to Radiotherapy and Immuno-Biological Therapies
N/ARecruiting
3,600 participants
Started: Sep 13, 2019 · Completed: Sep 30, 2025
2 conditions1 sponsor1 location
NCT04062266
AZA + Venetoclax as Maintenance Therapy in Patients With AML in Remission
PHASE2Active, not recruiting
50 participants
Started: Sep 13, 2019 · Completed: Oct 31, 2030
6 conditions3 sponsors1 location
NCT03836196
Optimizing Prostate Cancer Treatment in Men With Advanced Local Disease
NARecruiting
105 participants
Started: Sep 13, 2019 · Completed: Feb 29, 2028
1 condition1 sponsor1 location
NCT04475952
Early Diagnosis of Upper Digestive Tract Disease
N/ARecruiting
180 participants
Started: Sep 13, 2019 · Completed: Sep 13, 2025
4 conditions1 sponsor1 location
NCT03894917
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
N/ARecruiting
84 participants
Started: Sep 13, 2019 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06081439
Validating Immunological Markers Associated With Mental Fatigue in Graves' Disease
N/ARecruiting
430 participants
Started: Sep 12, 2019 · Completed: Dec 20, 2025
2 conditions1 sponsor1 location
NCT03911388
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
PHASE1Recruiting
24 participants
Started: Sep 12, 2019 · Completed: Sep 1, 2027
33 conditions3 sponsors3 locations
NCT04067336
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
PHASE1/PHASE2Recruiting
263 participants
Started: Sep 12, 2019 · Completed: Oct 16, 2028
7 conditions1 sponsor56 locations
NCT04015154
A Post-Market Clinical Evaluation of the Treatment of Femur Fractures With the Femoral Nail PF
N/ARecruiting
60 participants
Started: Sep 12, 2019 · Completed: Jun 30, 2025
1 condition1 sponsor5 locations
NCT03661255
Promoting Community Conversations About Research to End Native Youth Suicide in Rural Alaska
NAActive, not recruiting
1,491 participants
Started: Sep 12, 2019 · Completed: Dec 15, 2025
1 condition4 sponsors1 location
NCT04015128
A Post-Market Clinical Evaluation of the Treatment of Femur Fractures With the Femoral Nail GT
N/ARecruiting
60 participants
Started: Sep 12, 2019 · Completed: Dec 31, 2024
1 condition1 sponsor6 locations
NCT04095156
Autoreactive B Cells in Membranous Nephropathy
N/ARecruiting
86 participants
Started: Sep 12, 2019 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT04903041
A Cardiac Registry to Evaluate and Manage the hsTnI Categorical CVD Risk in Subjects Undergoing Preventive Health Checks (PHC).
N/ARecruiting
300,000 participants
Started: Sep 12, 2019 · Completed: Sep 12, 2030
1 condition2 sponsors6 locations
NCT06321666
Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to the Bone
NAActive, not recruiting
58 participants
Started: Sep 12, 2019 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT03920007
Study of Subretinally Injected ATSN-101 Administered in Patients With Leber Congenital Amaurosis Caused by Biallelic Mutations in GUCY2D
PHASE1/PHASE2Active, not recruiting
15 participants
Started: Sep 12, 2019 · Completed: May 19, 2027
3 conditions1 sponsor2 locations
NCT04121455
Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated Patients
PHASE1/PHASE2Active, not recruiting
117 participants
Started: Sep 12, 2019 · Completed: Dec 31, 2028
1 condition1 sponsor6 locations
NCT04122469
The Role of Stereo-tActic BoDy RadIotherApy iN Oligo-Progressive MalignanT Disease
NARecruiting
130 participants
Started: Sep 11, 2019 · Completed: Sep 30, 2027
3 conditions1 sponsor1 location
NCT03984695
Sexual Health Empowerment for Women's Health
NAActive, not recruiting
279 participants
Started: Sep 11, 2019 · Completed: Mar 31, 2025
4 conditions2 sponsors1 location
NCT04117360
Orthognathic Speech Pathology: Phonetic Contrasts of Patients With Dental Discrepancies Pre- and Post-Treatment Analyses
N/ARecruiting
180 participants
Started: Sep 11, 2019 · Completed: Dec 31, 2026
10 conditions2 sponsors1 location
NCT04088851
"Hepatic Substrate Flux Rates in Type 2 Diabetes"
NAActive, not recruiting
23 participants
Started: Sep 11, 2019 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04027647
Phase 2 Study of Dacomitinib in NSCLC
PHASE2Active, not recruiting
118 participants
Started: Sep 11, 2019 · Completed: Mar 31, 2026
5 conditions2 sponsors9 locations
NCT04025840
Perioperative Epidural Block and Dexamethasone in Pancreatic Cancer Surgery
PHASE4Active, not recruiting
260 participants
Started: Sep 11, 2019 · Completed: Nov 30, 2026
5 conditions3 sponsors1 location
NCT03766048
LAparoscopic Preventive PRErectal Mesh
NARecruiting
834 participants
Started: Sep 11, 2019 · Completed: Dec 31, 2025
1 condition2 sponsors9 locations
NCT04060706
Heuristics, Algorithms and Machine Learning: Evaluation & Testing in Radiation Therapy
N/ARecruiting
310 participants
Started: Sep 11, 2019 · Completed: Jan 1, 2028
1 condition3 sponsors1 location
NCT04076059
An Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Chinese Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
PHASE3Active, not recruiting
180 participants
Started: Sep 11, 2019 · Completed: Dec 31, 2028
1 condition1 sponsor28 locations
NCT04145882
Efficacy of Additional Osteotomies to Correct Hallux Valgus
NAActive, not recruiting
515 participants
Started: Sep 11, 2019 · Completed: Sep 11, 2026
1 condition1 sponsor4 locations
NCT05112614
Role of Gut Microbiome in Cancer Therapy
N/ARecruiting
3,000 participants
Started: Sep 11, 2019 · Completed: Oct 1, 2030
2 conditions1 sponsor3 locations
NCT03808558
Phase 2 Study of TVB-2640 in KRAS Non-Small Cell Lung Carcinomas
PHASE2Active, not recruiting
18 participants
Started: Sep 11, 2019 · Completed: Dec 1, 2026
1 condition4 sponsors2 locations
NCT06515171
Efficacy and Safety of Bowel Preparation for Patency Capsule in CD Patients Who Previously Failed Patency Capsule
N/AActive, not recruiting
400 participants
Started: Sep 11, 2019 · Completed: Jul 1, 2025
2 conditions1 sponsor1 location
NCT03620903
Efficacy of First Line B-RI for Treatment Naive Waldenström's Macroglobulinemia
PHASE2Active, not recruiting
53 participants
Started: Sep 11, 2019 · Completed: Sep 30, 2029
1 condition6 sponsors12 locations
NCT03999723
Combining Active and Passive DNA Hypomethylation
PHASE2Recruiting
196 participants
Started: Sep 11, 2019 · Completed: Dec 31, 2027
3 conditions14 sponsors10 locations
NCT04007874
Oral Contraceptive Pill Compared With Vitamin E in Women With Migraine
PHASE3Recruiting
360 participants
Started: Sep 10, 2019 · Completed: Dec 31, 2024
2 conditions4 sponsors1 location
NCT04047953
Paclitaxel (Albumin-bound) Combined With Oxaliplatin and S-1 Conversion Therapy for Gastric Adenocarcinoma
NARecruiting
95 participants
Started: Sep 10, 2019 · Completed: Nov 30, 2026
1 condition1 sponsor1 location